Related Experiment Video
Updated: Aug 20, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Negative regulation of adipogenesis from human mesenchymal stem cells by Jun N-terminal kinase
Sachiko Tominaga1, Tomohiro Yamaguchi, Shin-Ichiro Takahashi
1Graduate School of Life Science, Himeji Institute of Technology, University of Hyogo, 3-2-1 Koto, Kamigori, Hyogo 678-1297, Japan.
Abstract:
Human mesenchymal stem cells (hMSCs) are capable of differentiating into several cell types including adipocytes, osteoblasts, and chondrocytes, under appropriate culture conditions. We found that SP600125, an inhibitor of Jun N-terminal kinase (JNK), promoted adipogenesis whereas it repressed osteogenesis from hMSCs. SP600125 increased the expression of adipogenic transcription factors, CCAAT/enhancer-binding proteins alpha and beta as well as peroxisome proliferator-activated receptor gamma2, which suggested that the chemical acted on the early steps of transcriptional regulatory cascade in adipogenesis. A gene reporter assay showed that SP600125 and a dominant negative JNK promoted a transcriptional activity dependent on the cAMP-response element (CRE). Thus, JNK represses adipogenesis from hMSCs probably by, at least in part, inhibiting the transactivating function of CRE-binding protein. Another action of JNK, phosphorylation at Ser(307) of insulin receptor substrate-1, was also predicted to contribute to the repression of adipogenesis.
Insights
Jun N-terminal kinase (JNK) inhibition using SP600125 promotes human mesenchymal stem cell (hMSC) adipogenesis while repressing osteogenesis. JNK signaling negatively regulates adipogenesis by affecting transcription factors and CRE-binding protein activity.
Area of Science:
- Cell Biology
- Molecular Biology
- Stem Cell Research
Background:
- Human mesenchymal stem cells (hMSCs) exhibit multipotency, differentiating into adipocytes, osteoblasts, and chondrocytes.
- The precise molecular mechanisms regulating hMSC differentiation pathways remain under investigation.
Purpose of the Study:
- To investigate the role of Jun N-terminal kinase (JNK) signaling in regulating adipogenesis and osteogenesis in hMSCs.
- To elucidate the molecular targets of JNK inhibition in the context of stem cell differentiation.
Main Methods:
- Treatment of hMSCs with SP600125, a specific JNK inhibitor.
- Analysis of adipogenic and osteogenic gene expression.
- Gene reporter assays to assess transcriptional activity.
Main Results:
- SP600125 treatment promoted adipogenesis and repressed osteogenesis in hMSCs.
- JNK inhibition upregulated key adipogenic transcription factors (C/EBPα, C/EBPβ, PPARγ2).
- SP600125 and dominant-negative JNK enhanced cAMP-response element (CRE) transcriptional activity, indicating JNK's repressive role.
Conclusions:
- JNK signaling plays a critical role in repressing adipogenesis in hMSCs.
- JNK likely inhibits adipogenesis by suppressing the transactivating function of CRE-binding protein.
- JNK-mediated phosphorylation of insulin receptor substrate-1 may also contribute to adipogenesis repression.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Mesenchymal Stem Cells
Master Transcription Regulators
TGF - β Signaling Pathway

